Investigators study the association between increased treatment coverage and eating disorder-related mortality.
The New Drug Application (NDA) for viloxazine hydrochloride (SPN-812; Supernus Pharmaceuticals), a serotonin norepinephrine modulating agent, has been submitted to the Food and Drug Administration (FDA) for the treatment of pediatric patients with attention deficit hyperactivity disorder (ADHD).
Watching television and playing video games negatively affects academic performance in children and adolescents but overall screen time does not, according to research results published in JAMA Pediatrics. Television and video games both affected composite scores, while television negatively impacted language and mathematics skills. In a systematic review and meta-analysis, investigators aimed to determine whether…
Pediatricians are likely to encounter children of undocumented parents during practice, making it essential for practitioners to be aware of the unique vulnerabilities faced by this population, as well as appropriate clinical procedure.
Symptoms of depression are associated with oral contraceptive use in 16-year-old girls compared with adolescents and young women up to 25 years of age.
The authors examined 3 hypotheses: internalized stigma would be a stronger predictor of barriers to seeking mental health care than perceived stigma, alienation would be a stronger predictor of barriers than other components, and depression severity would modify the relationship of depression stigma and barriers to care.
Authors say there is need for early follow-up care and attention to risk reduction strategies.
Researchers used patient databases to investigate the association between obesity treatment interventions with a dietary component and the change in symptoms of depression and anxiety in pediatric patients who were overweight or obese.
Depression is linked to increased clinical burden in patients with COPD.
Adverse childhood experiences significantly linked to poorer health outcomes, health risk behaviors.
Borderline personality traits, depression associated with extent of midlife cardiometabolic risk.
Higher rates of hopelessness, loneliness, anhedonia, social anxiety, and younger age were highly correlated with suicidal ideation in patients with major depressive disorder, based on a review of qualitative data.
Treatment with lofexidine may provide better control of the symptoms of opioid withdrawal syndrome compared with placebo.
Discontinuing short- or long-term use of esketamine nasal spray for treatment-resistant depression may not be associated with withdrawal symptoms.
Dasotraline may reduce compulsions and obsessive thoughts in adults with binge eating disorder.
Patients with schizophrenia or a mood disorder who switched antipsychotic treatment had an increased likelihood for relapse, healthcare resource utilization, and extrapyramidal symptoms.
There is little evidence to suggest that cannabinoids improve mental disorders.
Researchers sought to document and describe the contributions of certified PAs across practice areas in addressing mental health conditions.
For patients with major depressive disorder, neither second-generation antidepressants nor cognitive behavioral therapy offers consistently superior cost-effectiveness.
Off-label use of oxcarbazepine and amantadine HCl appeared effective in maintaining improved symptomology in adolescent female patients with borderline personality disorder.